James H Flory (James Flory)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 22

Top Topics

Chronic Kidney Disease

Tyrosine Kinase

Top Venues

Diabetes, obesity & metabolism

Journal of evaluation in clinical practice

Journal of general internal medicine

This page only lists publications with an associated author ORCID identifier.

Publications

James H Flory, Jessica S Ancker, Scott Y H Kim, Gilad Kuperman, Aleksandr Petrov, Andrew Vickers
The Large Language Model GPT-4 Compared to Endocrinologist Responses on Initial Choice of Antidiabetic Medication under Conditions of Clinical Uncertainty. Diabetes care (2024)
Isabel Marie Astrachan, James H Flory, Scott Yung Ho Kim
Individualized clinical decisions within standard-of-care pragmatic clinical trials: Implications for consent. Clinical trials (London, England) (2024)
Qoua L Her, Sara Z Dejene, Sherin Ismail, Tiansheng Wang, Michele Jonsson-Funk, Virigina Pate, Jea Young Min, James H Flory
Validation of an international classification of disease, tenth revision, clinical modification (ICD-10-CM) algorithm in identifying severe hypoglycaemia events for real-world studies. Diabetes, obesity & metabolism 26 (4) (2024)
James H Flory, Yongkang Zhang, Samprit Banerjee, Fei Wang, Jea Y Min, Alvin I Mushlin
Application of a data continuity prediction algorithm to an electronic health record-based pharmacoepidemiology study. Journal of evaluation in clinical practice 30 (4) (2024)
Isabel Marie Astrachan, James H Flory, Scott Yung Ho Kim
Taking clinical decisions seriously in standard-of-care pragmatic clinical trials. Clinical trials (London, England) (2024)
Qoua L Her, Sara Z Dejene, Sherin Ismail, Tiansheng Wang, Michele Jonsson-Funk, Virigina Pate, Jea Young Min, James H Flory
Validation of an international classification of disease, tenth revision, clinical modification (ICD-10-CM) algorithm in identifying severe hypoglycaemia events for real-world studies. Diabetes, obesity & metabolism 26 (4) (2024)
James H Flory, Yongkang Zhang, Samprit Banerjee, Fei Wang, Jea Y Min, Alvin I Mushlin
Application of a data continuity prediction algorithm to an electronic health record-based pharmacoepidemiology study. Journal of evaluation in clinical practice (2024)
Qoua L Her, Sara Z Dejene, Sherin Ismail, Tiansheng Wang, Michele Jonsson-Funk, Virigina Pate, Jea Young Min, James H Flory
Validation of an international classification of disease, tenth revision, clinical modification (ICD-10-CM) algorithm in identifying severe hypoglycaemia events for real-world studies. Diabetes, obesity & metabolism (2024)
Michael A Weintraub, Dazhi Liu, Raymond DeMatteo, Marcus DaSilva Goncalves, James H Flory
Sodium-Glucose Cotransporter-2 Inhibitors for Hyperglycemia in Phosphoinositide 3-kinase Pathway Inhibition. Research square (2023)
Michael A Weintraub, Dazhi Liu, Raymond DeMatteo, Marcus DaSilva Goncalves, James H Flory
Sodium-glucose cotransporter-2 inhibitors for hypergycemia in phosphoinositide 3-kinase pathway inhibition. Breast cancer research and treatment (2023)
James H Flory, Jessica S Ancker, Scott Yung Ho Kim, Gilad Kuperman, Andrew Vickers
Decision architecture randomisation: extremely efficient clinical trials that preserve clinician and patient choice? BMJ evidence-based medicine (2023)
Alex Huang, Amy L Tin, Andrew J Vickers, Armin Shahrokni, James H Flory
Preoperative glucose in surgical oncology patient is not associated with postoperative outcomes after adjustment for frailty. Journal of surgical oncology (2023)
Kacie Bogar, Colleen M Brensinger, Sean Hennessy, James H Flory, Michelle L Bell, Christopher Shi, Warren B Bilker, Charles E Leonard
Climate Change and Ambient Temperature Extremes: Association With Serious Hypoglycemia, Diabetic Ketoacidosis, and Sudden Cardiac Arrest/Ventricular Arrhythmia in People With Type 2 Diabetes. Diabetes care 45 (11) (2022)
Ghadeer K Dawwas, James H Flory, Sean Hennessy, Charles E Leonard, James D Lewis
Comparative Safety of Sodium-Glucose Cotransporter 2 Inhibitors Versus Dipeptidyl Peptidase 4 Inhibitors and Sulfonylureas on the Risk of Diabetic Ketoacidosis. Diabetes care 45 (4) (2022)
Jea Young Min, Will Simmons, Samprit Banerjee, Fei Wang, Nicholas Williams, Yongkang Zhang, April B Reese, Alvin I Mushlin, James H Flory
Association between antidiabetic drug use and the risk of COVID-19 hospitalization in the INSIGHT Clinical Research Network in New York City. Diabetes, obesity & metabolism 24 (7) (2022)
James H Flory, Dominique Guelce, Crispin Goytia, Jing Li, Jea Young Min, Al Mushlin, Jeremy Orloff, Victoria Mayer
Prescriber Uncertainty as Opportunity to Improve Care of Type 2 Diabetes with Chronic Kidney Disease: Mixed Methods Study. Journal of general internal medicine (2022)
Jeremy N Orloff, Jea Young Min, Alvin Mushlin, James H Flory
Safety and effectiveness of metformin in patients with reduced renal function: A systematic review. Diabetes, obesity & metabolism 23 (9) (2021)
James H Flory, Jing Li, Ghadeer K Dawwas, Charles E Leonard
Compared to commercially insured patients, Medicare advantage patients adopt newer diabetes drugs more slowly and adhere to them less. Endocrinology, diabetes & metabolism 4 (3) (2021)
Alex Huang, Xian Wu, Jeremy Orloff, Jea Young Min, James H Flory
Rates of Metformin Use in Stage 3b Chronic Kidney Disease Rose After FDA Label Change. Journal of general internal medicine 36 (10) (2021)
James H Flory, Clifford J Bailey, Catherine M Viscoli
Response to Comment on Flory et al. Reports of Lactic Acidosis Attributed to Metformin, 2015-2018. Diabetes Care 2020;43:244-246. Diabetes care 43 (10) (2021)
James H Flory, Alvin I Mushlin
Effect of Cost and Formulation on Persistence and Adherence to Initial Metformin Therapy for Type 2 Diabetes. Diabetes care 43 (6) (2020)
James H Flory, Sean Hennessy, Clifford J Bailey, Catherine M Viscoli
Reports of Lactic Acidosis Attributed to Metformin, 2015-2018. Diabetes care 43 (1) (2019)